Cambrian Bio
Drug DiscoveryWebsite
Cambrian Bio valuation and funding history | Last updated: December 12, 2025 | 5 funding rounds
Current Valuation
N/A
As of December 12, 2025
Total Funding Raised
$204.0M
Across 5 rounds
Last Round
Later Stage VC
$23.8M
Last Funding
Dec 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| N/A | Unknown | Undisclosed | N/A | - |
| December 12, 2025 | Later Stage VC | $23.8M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Cambrian Bio is currently valued at N/A as of December 12, 2025. The company has raised a total of $204.0M in funding across 5 funding rounds.
What is Cambrian Bio Worth in 2026?
Cambrian Bio is a leading private company in the Drug Discovery sector. Track Cambrian Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Cambrian Bio Valuation is Determined
Private company valuations like Cambrian Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.